Jason Aryeh Insider Profile

25 Followers
Jason Aryeh, Director at Ligand Pharma, holds 134.70K shares in Ligand Pharma (Ticker: LGND), holds 54.79K shares in Aralez Pharmaceuticals (Ticker: ARLZQ), holds ― shares in Immunomedics (Ticker: IMMU).
tipranks
Jason Aryeh

Jason Aryeh
Ligand Pharma (LGND)
Director

Ranked #60,523 out of 98,042 Corporate Insiders

Profitable Transactions

36%
9 out of 25 Profitable Transactions

Average Return

-2.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$14M
95.54%
3.83%
0.63%
0.00%
A breakdown of Jason Aryeh's holdings

Insider Roles

Ligand Pharma
(LGND)
Director
Orchestra BioMed Holdings
(OBIO)
Director
Vaxart
(VXRT)
Director
Anebulo Pharmaceuticals
(ANEB)
Director
Roles that Jason Aryeh holds in companies

Most Profitable Insider Trade

Stock:
Ligand Pharma
(LGND)
Rating:Informative Buy
Date:Oct 09, 2014 - Oct 09, 2015
Return:+104.80%
The most profitable trade made by Jason Aryeh

Jason Aryeh's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ligand Pharma
Jun 18, 2024
Director
Uninformative Buy
$13.79M
ARLZQ
Aralez Pharmaceuticals
May 24, 2017
Informative Sell
556.48K
$109.57
IMMU
Immunomedics
MACK
Merrimack Pharmaceuticals
Jul 18, 2019
Informative Buy
1.64K
$57.52K
Anebulo Pharmaceuticals
Director
Orchestra BioMed Holdings
Jun 21, 2024
Director
Uninformative Buy
$552.35K
NVLNF
Novelion Therapeutics
May 17, 2017
Informative Buy
3.23K
$375.91K
Vaxart
Mar 17, 2011
Director
Informative Sell
28.76K
$90.93K
List of latest transactions for each holding click on a transaction to see Jason Aryeh's performance on stock

Jason Aryeh insider profile FAQ

What is the percentage of profitable transactions made by Jason Aryeh?
The percentage of profitable transactions made by Jason Aryeh is 36%.
    What is the average return per transaction made by Jason Aryeh?
    The average return per transaction made by Jason Aryeh is -2.60%.
      What stocks does Jason Aryeh hold?
      Jason Aryeh holds: LGND, ARLZQ, IMMU, MACK, ANEB, OBIO, NVLNF, VXRT stocks.
        What was Jason Aryeh’s latest transaction?
        Jason Aryeh latest transaction was an Uninformative Buy of ―.
          What was Jason Aryeh's most profitable transaction?
          Jason Aryeh’s most profitable transaction was an Informative Buy of LGND stock on October 9, 2014. The return on the trade was 104.80%.
            What is Jason Aryeh's role in Ligand Pharma?
            Jason Aryeh's role in Ligand Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.